| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Sale | $371,504 | -1,795 | -3.4% | $206.97 | 51,439 | 31 Aug 2023 | Direct | F1, F2 |
| holding | SGEN | Common Stock | 119,471 | 31 Aug 2023 | by Trust |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/21/2019 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). |
| F2 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |